Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
0 hedge funds and large institutions have $0 invested in Loxo Oncology, Inc in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $65K → $0 (-$65K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IUHSA
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
|
-$65K |
LOXO Hedge Fund Activity: Q2 2019 in Review
0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2019, worth a combined $0 — down 100% from $65K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LOXO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Itau Unibanco Holding S.A., exiting entirely with an estimated $65K sold.
- 0 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2019, down from 1 in Q1 2019.
- Funds reported $0 of Loxo Oncology, Inc stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new Loxo Oncology, Inc positions in Q2 2019 and 1 closed out, a net change of -1 holder.
- The largest Loxo Oncology, Inc seller in Q2 2019 was Itau Unibanco Holding S.A., an estimated $65K sold.
Based on aggregated 13F filings for Q2 2019.